Paysign (PAYS) Small-Cap Growth Virtual Investor Conference summary

Business overview and strategy

• Provides prepaid card programs and integrated payment solutions for diverse industries, with a strong focus on healthcare and pharmaceuticals.

• Operates a proprietary, cloud-based platform, managing all aspects of the prepaid card lifecycle in-house, including customer service and program management.

• Differentiates through rapid solution delivery, tailored offerings, and 24/7 bilingual support.

• Maintains strong compliance standards, partnering with major card networks and third-party banks for issuing.

• Leadership team has deep experience in payments and banking, supporting innovation and operational excellence.

Financial performance and growth

• Achieved a market cap of over $220 million, with trailing 12-month revenues of $50.3 million and no debt.

• First quarter 2024 revenues reached $13.2 million, up from $10.14 million in Q1 2023, with Adjusted EBITDA of $1.7 million.

• Patient affordability business grew 350% year-over-year, now representing 18% of Q1 revenues.

• Plasma business continues steady organic growth in the upper single to low double digits.

• Revenue is fee-based, diversified across cardholder fees, interchange, program management, and claims fees.

Market position and opportunities

• Holds nearly 40% share of the $120 million plasma payments market, serving 469 plasma centers.

• Patient affordability (copay) business has a $500 million addressable market, with 53 programs and significant growth potential.

• Serves 6.5 million cardholders across about 600 programs, primarily in healthcare but also in payroll, gift cards, and corporate disbursements.

• Offers digital banking, same-day wage access, and open gift card solutions, expanding reach beyond core healthcare markets.

• Focuses on transparent pricing and proprietary IP to win new business, especially in pharmaceuticals.